Department of Medical Oncology and Pneumology, University of Tübingen, Tübingen, Germany,
Erbe Elektromedizin GmbH, Tübingen, Germany.
Respiration. 2020;99(3):248-256. doi: 10.1159/000506017. Epub 2020 Feb 26.
Forceps biopsy (FB) is still the most popular procedure for the bronchoscopic sampling of lung tissue. However, it has limitations like inadequate sample size and crush artifacts. Cryobiopsy (CB) has been introduced to obtain bronchoscopic biopsies with improved diagnostic yield compared to FB. Limitations of CB are the need to retract the cryoprobe en bloc with bronchoscope because samples are larger than the working channel and the variations of the freezing power of the reusable CB (rCB). Therefore, 3 new disposable cryoprobes (dCB) have been developed with different outer diameters: 1.1 mm (CB11-S) that can be retracted through the working channel of the bronchoscope, 1.7 mm (CB17) and 2.4 mm (CB24n), respectively.
The aim was to evaluate the new cryoprobes with regard to feasibility, specimen area, specimen quality and complications.
We compared biopsy samples of the new probes with those obtained by FB and by rCB in an in vivo (porcine) model. A flexible bronchoscope was used to perform biopsy at 4 different locations at the upper and lower lobes of the right and left lung, respectively. The biopsies were taken under fluoroscopic control. The biopsy tool and activation times were allocated randomly. Altogether 204 biopsy procedures were performed.
The sample quality of the dCB was superior to that of FB (all p < 0.05) and not significantly different to the rCB sample quality. Mean specimen sample area of all CB was significantly larger compared to FB (p < 0.05). The sample area of the small cryoprobe (CB11-S) was significantly smaller compared to the other CB probes (p < 0.05). No severe bleedings occurred. Pneumothoraces were detected in 3 of the 7 pigs.
We conclude that CB with the new single-use instruments are feasible and represent a viable option to improve the diagnostic accuracy of histopathological evaluation compared to FB.
活检钳(FB)仍然是肺组织支气管镜取样最常用的方法。然而,它有一些局限性,如样本量不足和压碎伪影。冷冻活检(CB)的引入提高了与 FB 相比的诊断收益。CB 的局限性在于需要将冷冻探针整体缩回支气管镜,因为样本比工作通道大,并且可重复使用的 CB(rCB)的冷冻功率存在差异。因此,已经开发了 3 种新型一次性冷冻探针(dCB),其外径分别为 1.1 毫米(CB11-S),可通过支气管镜的工作通道缩回,1.7 毫米(CB17)和 2.4 毫米(CB24n)。
目的是评估新冷冻探针的可行性、标本面积、标本质量和并发症。
我们在体内(猪)模型中比较了新探针与 FB 和 rCB 的活检样本。使用柔性支气管镜在右肺和左肺的上叶和下叶的 4 个不同部位进行活检。活检在透视控制下进行。活检工具和激活时间随机分配。总共进行了 204 次活检程序。
dCB 的样本质量优于 FB(均 p < 0.05),与 rCB 样本质量无显著差异。所有 CB 的平均标本面积均明显大于 FB(p < 0.05)。小冷冻探针(CB11-S)的标本面积明显小于其他 CB 探针(p < 0.05)。未发生严重出血。7 头猪中有 3 头出现气胸。
我们得出结论,与 FB 相比,使用新型一次性仪器进行 CB 是可行的,并且是提高组织病理学评估诊断准确性的可行选择。